Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: Crescent Biopharma Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Spero Therapeutics Inc. May 29, 202493.1%
-
MacroGenics Inc. May 21, 202488.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 23, 2026 | Spero Therapeutics Inc. | Grant or award | +10,000 | — | — |
| May 18, 2026 | MacroGenics Inc. | Option exercise | +3,750 | — | — |
| Jun 12, 2025 | Spero Therapeutics Inc. | Grant or award | +20,000 | — | — |
| May 20, 2025 | MacroGenics Inc. | Option exercise | +6,500 | — | — |
| May 29, 2024 | Spero Therapeutics Inc. | Grant or award | +20,000 | — | — |
| May 20, 2024 | MacroGenics Inc. | Option exercise | +4,500 | — | — |
| Oct 5, 2023 | Spero Therapeutics Inc. | Grant or award | +20,000 | — | — |
Questions about Scott Thomas Jackson
What boards is Scott Thomas Jackson on?
Scott Thomas Jackson sits on the boards of Crescent Biopharma Inc., MacroGenics Inc. and Spero Therapeutics Inc.
How long has Scott Thomas Jackson served on boards?
Our records show at least 10 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.